Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd has secured a significant AUD $6.75 million R&D Tax Incentive rebate from the Australian Taxation Office ...

Recce Pharmaceuticals (Recce) has obtained approval from the Human Research Ethics Committee in Indonesia to initiate a registrational Phase III trial of its RECCE 327 (R327G) as a topical gel ...

About Recce Pharmaceuticals Ltd Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health problems of ...

play videoSecretary of Smock Makers Association in the Northern Region, Mohammed Ali Abdul Somed Secretary of Smock Makers Association at Morshe Market in the Northern Region, Mohammed Ali Abdul ...

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd. is nearing the completion of its Phase II clinical trial for RECCE 327 Topical Gel, a synthetic anti ...

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd’s recent Annual General Meeting saw all proposed resolutions passed, showcasing strong shareholder support ...

A Phase II clinical trial for acute bacterial skin and skin structure infections reaches a dosing milestone. Clinical stage biotech company Recce Pharmaceuticals (ASX:RCE) is developing a new ...

Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new diabetic foot infection treatment trial from Recce Pharmaceuticals. In this episode, host Sarah Hughan tells all ...